Our finding with the MCT4−/− mice suggest MCT4 is a driver of progression to oral squamous cell cancer and MCT4 inhibitors could have clinical benefits for preventing invasive HNSCC. The gene discussed is SLC16A3; the disease is head and neck squamous cell carcinoma.